Banks, OR, United States of America

Daniel Streblow

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 75(Granted Patents)


Location History:

  • Tigard, OR (US) (2001 - 2002)
  • Banks, OR (US) (2023 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Streblow

Introduction

Daniel Streblow is a notable inventor based in Banks, Oregon, who has made significant contributions to the field of antiviral agents. With a total of four patents to his name, his work focuses on developing compounds that can effectively combat various viral infections.

Latest Patents

One of Streblow's latest patents involves the use of 6-aza-nucleoside prodrugs as antiviral agents for treating a wide range of viral infections. This patent addresses the need for effective treatments against viruses such as HIV, HPV, and COVID-19, among others. Another significant patent pertains to 2-pyrimidone analogs, which are designed to inhibit infections caused by alphaviruses, including chikungunya and Eastern equine encephalitis. These innovations highlight his commitment to advancing antiviral therapies.

Career Highlights

Throughout his career, Daniel Streblow has worked with esteemed organizations such as Oregon Health & Science University and Southern Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Cecilia E. Soderberg-Naucler and Jay A. Nelson. Their collaborative efforts have further enhanced the impact of Streblow's research and innovations.

Conclusion

Daniel Streblow's work in developing antiviral agents showcases his dedication to addressing critical health challenges. His patents and collaborations reflect a strong commitment to innovation in the field of virology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…